Concentration-dependent inhibition of human ENaC current
Cell-based study · HEK293T/17 cells expressing human αβγ ENaCeGFP; all three wild-type subunits bear N-terminal tags. [1]
Amiloride inhibited ENaC-mediated Na+ current. Reported IC50 values were similar across holding potentials from −60 to 0 mV; the authors found no voltage dependence over this range. These are functional cellular measurements, not binding affinities.
| Endpoint | Reported result | Reference |
|---|---|---|
| Inhibition of blocker-sensitive Na+ current through tagged human αβγ ENaC | IC50 −60 mV: 86.34 ± 27.04 nM; −40 mV: 80.25 ± 11.37 nM; −20 mV: 80.05 ± 8.78 nM; 0 mV: 97.14 ± 21.62 nM (mean ± SEM; five independent experiments) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 nM, 10 nM, 100 nM, 1 μM, 10 μM and 100 μM
- Method
- Extracellular application during whole-cell patch-clamp recording in 150 mM NaCl solution, pH 7.4; holding potentials −60, −40, −20 and 0 mV.
- Co-treatment
- Blockers tested separately. Cells had been maintained with 500 nM phenamil mesylate before recording; the recording dose-response solutions are described separately.
- Reported limits
- Duration per concentration and stock solvent not specified in the selected recording description. Exact hydration stoichiometry not supplied. Pretreatment conditions should be considered when transferring this assay.
Methods and source locations
Compound reported in the paper: Amiloride hydrochloride hydrate; Compound label in the paper: Amiloride
Molar pharmacology of amiloride in a recombinant cellular model; the reported material was hydrochloride hydrate, not verified A10064.
Table 1 (amiloride column, IC50 values in nM); Figure 1—figure supplement 1h–i and caption; Materials and methods: key resources table, Construct design, Whole cell patch clamp experiments
Inhibition of blocker-sensitive Na+ current through tagged human αβγ ENaC: Whole-cell patch clamp in HEK293T/17 cells expressing ENaCeGFP. Blocker-sensitive current defined using 100 μM blocker and normalized to the no-blocker response. IC50 measured at four holding potentials. — Table 1 (amiloride column, IC50 values in nM); Figure 1—figure supplement 1h–i and caption; Materials and methods: key resources table, Construct design, Whole cell patch clamp experiments